Vanyukov MM - Search Results

1

Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

Kirillova GP, Hrutkay RJ, Shurin MR, Shurin GV, Tourkova IL, Vanyukov MM. Kirillova GP, et al. Among authors: vanyukov mm. J Neurosci Methods. 2008 Sep 30;174(2):272-80. doi: 10.1016/j.jneumeth.2008.07.018. Epub 2008 Aug 5. J Neurosci Methods. 2008. PMID: 18721826 Free PMC article.

2

Salivary cortisol responses in prepubertal boys: the effects of parental substance abuse and association with drug use behavior during adolescence.

Moss HB, Vanyukov M, Yao JK, Kirillova GP. Moss HB, et al. Biol Psychiatry. 1999 May 15;45(10):1293-9. doi: 10.1016/s0006-3223(98)00216-9. Biol Psychiatry. 1999. PMID: 10349035

3

Antisociality, substance dependence, and the DRD5 gene: a preliminary study.

Vanyukov MM, Moss HB, Kaplan BB, Kirillova GP, Tarter RE. Vanyukov MM, et al. Am J Med Genet. 2000 Oct 9;96(5):654-8. doi: 10.1002/1096-8628(20001009)96:5<654::aid-ajmg11>3.0.co;2-y. Am J Med Genet. 2000. PMID: 11054773

4

Liability to substance use disorders: 1. Common mechanisms and manifestations.

Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB. Vanyukov MM, et al. Neurosci Biobehav Rev. 2003 Oct;27(6):507-15. doi: 10.1016/j.neubiorev.2003.08.002. Neurosci Biobehav Rev. 2003. PMID: 14599432 Review.

5

Liability to substance use disorders: 2. A measurement approach.

Vanyukov MM, Kirisci L, Tarter RE, Simkevitz HF, Kirillova GP, Maher BS, Clark DB. Vanyukov MM, et al. Neurosci Biobehav Rev. 2003 Oct;27(6):517-26. doi: 10.1016/j.neubiorev.2003.08.003. Neurosci Biobehav Rev. 2003. PMID: 14599433 Review.

6

Haplotypes of the monoamine oxidase genes and the risk for substance use disorders.

Vanyukov MM, Maher BS, Devlin B, Tarter RE, Kirillova GP, Yu LM, Ferrell RE. Vanyukov MM, et al. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):120-5. doi: 10.1002/ajmg.b.20105. Am J Med Genet B Neuropsychiatr Genet. 2004. PMID: 14755456

7

Social dominance mediates the association of testosterone and neurobehavioral disinhibition with risk for substance use disorder.

Tarter RE, Kirisci L, Kirillova GP, Gavaler J, Giancola P, Vanyukov MM. Tarter RE, et al. Among authors: vanyukov mm. Psychol Addict Behav. 2007 Dec;21(4):462-8. doi: 10.1037/0893-164X.21.4.462. Psychol Addict Behav. 2007. PMID: 18072828

8

The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction.

Vanyukov MM, Maher BS, Devlin B, Kirillova GP, Kirisci L, Yu LM, Ferrell RE. Vanyukov MM, et al. Psychiatr Genet. 2007 Dec;17(6):323-32. doi: 10.1097/YPG.0b013e32811f6691. Psychiatr Genet. 2007. PMID: 18075472

9

Physical maturation, peer environment, and the ontogenesis of substance use disorders.

Kirillova GP, Vanyukov MM, Kirisci L, Reynolds M. Kirillova GP, et al. Among authors: vanyukov mm. Psychiatry Res. 2008 Feb 28;158(1):43-53. doi: 10.1016/j.psychres.2007.02.017. Psychiatry Res. 2008. PMID: 18178256 Free PMC article.

10

Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability.

Vanyukov MM, Kirisci L, Moss L, Tarter RE, Reynolds MD, Maher BS, Kirillova GP, Ridenour T, Clark DB. Vanyukov MM, et al. Behav Genet. 2009 May;39(3):233-44. doi: 10.1007/s10519-009-9269-9. Epub 2009 Apr 18. Behav Genet. 2009. PMID: 19377872 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters